Statistics

Total Visits

Views
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial123

Total Visits Per Month

October 2023November 2023December 2023January 2024February 2024March 2024April 2024
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial32112201

Top country views

Views
United States56
Poland52
Sweden4
Ireland3
France2
China1
Germany1
Italy1
Jordan1
Ukraine1

Top cities views

Views
Warsaw52
Louisville24
Boardman6
San Ramon6
Ann Arbor4
Costa Mesa3
Dublin3
Ashburn2
Des Moines2
San Diego2